MU Home / Provost / MU Research / Funding / OGWP / Limited Submission Announcements / DRCRF

Limited Submission Announcements

	OGWP Home Staff/Contact Info Forms FAQ Faculty Expertise Faculty Grant Writer Institute Funder Info Grant Fact Sheet Grantsmanship Workshops Limited Submission Announcements Model Proposals Proposal Development Tools Publications

Last update
12.04.07

A A A

The Damon Runyon Cancer Research Fund announces a program to help physicians willing to devote their careers to the development and application of new diagnostic approaches and therapeutic strategies for cancer and cancer prevention through clinical investigation. Earmarked for young physicians wishing to commit themselves to substantive and innovative clinical research, the award bridges the gap between the research laboratory and patient care.

The Clinical Investigator Award offers solutions to three recognized realities:

1. Though there has never been a more pressing need or more promising time for clinical cancer research, fewer young physicians enter this area of investigation every year.
2. The number of institutions committed to training young physicians in the scientific discipline and methodologies of clinical investigation is critically low.
3. A major deterrent to physician commitment in clinical investigation is often the need to address major debts incurred during medical training.

Eligibility:

• The applicant may apply during the final year of subspecialty training or within the first two years of the junior faculty appointment.
• The applicant must be a U.S. citizen or permanent legal resident.
• The applicant must have received an M.D. or M.D./Ph.D. degree from an accredited institution and be board-eligible in a cancer or cancer-related specialty (e.g., oncology, pathology, radiation therapy, surgery, or hematology).
• The applicant must be nominated by his or her mentor and institution. The applicant is required to apply in conjunction with a mentor who is established in the field of clinical translational cancer research or cancer prevention and epidemiology and can provide the critical guidance needed during the period of the award.
• The applicant must commit to spending 80% of his/her time conducting research.
• In light of the Foundation’s partnership with Siemens Medical Solutions, in addition to candidates working in translational clinical oncology, the Foundation is interested in candidates whose research relates to or uses imaging technologies and molecular imaging in cancer.
  

Because MU is limited to two applications for this program, letters of intent must be submitted to the Office of Research, ltdsub@missouri.edu, no later than 4:00 pm Friday, January 26, 2008. Letters of intent should be limited to a 2-page biographical sketch for the nominee and a 2-page summary of the following: 1) proposed research project, its significance to the field of cancer and/or cancer prevention, and its adherence to the definition of clinical research; and 2) the mentor and proposed training plan.

URL for more information: http://www.drcrf.org/NETCOMMUNITY/Page.aspx?pid=260&srcid=230

This notice is being sent to deans, directors, and chairs in health science disciplines. Please forward it to faculty members who may be interested.

All limited submission announcements can be tracked by deadline via the Calendar at research.missouri.edu or by announcement date via the Limited Submissions listing at http://research.missouri.edu/ogwp/lsa.htm.

Research Main | Illumination | Funding | Compliance | Forms | Policies | Tech Transfer | Research Division | Links
Published by the Office of Research.